Cita APA

Shah, N. P., Rousselot, P., Schiffer, C., Rea, D., Cortes, J. E., Milone, J., . . . Saglio, G. (2016). Dasatinib in imatinib‐resistant or ‐intolerant chronic‐phase, chronic myeloid leukemia patients: 7‐year follow‐up of study CA180‐034. Am J Hematol.

Chicago Style Citation

Shah, Neil P., et al. "Dasatinib in Imatinib‐resistant or ‐intolerant Chronic‐phase, Chronic Myeloid Leukemia Patients: 7‐year Follow‐up of Study CA180‐034." Am J Hematol 2016.

Cita MLA

Shah, Neil P., et al. "Dasatinib in Imatinib‐resistant or ‐intolerant Chronic‐phase, Chronic Myeloid Leukemia Patients: 7‐year Follow‐up of Study CA180‐034." Am J Hematol 2016.